Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Solvation Shapes the Conformational Landscape of a Therapeutically Relevant SMN2 Splice-Site Defect

Created on 08 Jul 2026

Authors

Khaled, M., Leuschner, L., Palomino/Hernandez, O.

Abstract

The SMN2 exon 7 5' splice-site/U1 snRNA duplex contains an A$_{-1}$ bulge that weakens splice-site recognition and represents a therapeutically relevant RNA connectivity defect, yet its conformational landscape and coupling to solvation remain poorly understood. Here, we performed enhanced-sampling Hamiltonian replica-exchange molecular dynamics simulations of the SMN2 splice-site duplex using four explicit-solvent models (OPC, TIP4P-Ew, TIP3P, and SPC/E) and characterized the sampled ensemble using linear and machine-learned latent representations. Across representations, the A$_{-1}$ defect consistently populated three metastable conformational states distinguished by local duplex geometry, base stacking, hydrogen-bonding patterns, and solvent exposure. The relative populations of these states, together with first-shell hydration and Na$^+$ distributions around the defect, varied substantially across water models, demonstrating that hydration and ion organization actively shape the equilibrium between locally accommodated and solvent-exposed conformations of the SMN2 splice-site bulge. Our results shed light on the conformational components of this therapeutic RNA target and highlight the impact of solvation model as an important consideration for molecular simulations of RNA splice-site recognition and small-molecule repair.

Preprint server: bioRxiv
The authors list and abstract were imported from bioRxiv on 08 Jul 2026.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this preprint? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 10
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement